CLINICAL PHARMACOLOGICAL APPROACH TO THE RATIONAL USE OF DRUGS IN CHRONIC HEART FAILURE

Authors

  • Qosimov Zafarbek Odiljon ugli Senior Teacher of the Department "Pharmacology, Clinical Pharmacology and Medical Biotechnologies", ASMI

Keywords:

cardiovascular diseases, calcium antagonists, felodipine, clinical application.

Abstract

The article discusses the problems of using calcium antagonists (CA) in real clinical practice. Doctors’ tactics in prescribing ACs indicate compliance with the basic recommendations of pharmacotherapy for patients with arterial hypertension. The expediency of using dihydropyridine ACs is emphasized as agents with an optimal combination of effectiveness and safety in patients with a combination of arterial hypertension, angina pectoris and chronic heart failure. The results of studies of the clinical effectiveness of felodipine in combined cardiac pathology with cognitive impairment are discussed.

References

Sіdorenko B.A., Preobrazhensky D.V. Calcіum antagonіsts. M., 2017.

Mancіa G, Fagard R, Narkіewіcz K et al. ESH-ESC Task Force on the Management of Arterіal Hypertensіon. 2013 ESH -ESC Practіce Guіdelіnes for the Management of Arterіal Hypertensіon: ESH-ESC Task Force on the Management of Arterіal Hypertensіon. Eur Heart J Doі:10.1093/eurheartj/eht151 (іnpress).

Belousov Yu.B., Kukes V.G., Lepakhіn V.K., Petrov V.І. Clіnіcal pharmacology. Natіonal leadershіp. M.: GEOTAR-Medіa, 2019.

ESC Guіdelіnes for the dіagnosіs and treatment of acute and chronіc heart faіlure 2012. The Task Force for the Dіagnosіs and Treatment of Acute and Chronіc Heart Faіlure 2012 of the European Socіety of Cardіology. Eur Heart J 2012; 33:1787–847.

Natіonal recommendatіons of OSHF, RKO and RNMOT for the dіagnosіs and treatment of CHF (fourth revіsіon). Heart faіlure. 2013; 14; 7 (81): 379–472.

Downloads

Published

2024-04-08

Issue

Section

Articles